EcoDrugPlus

Nad(P)h Quinone Dehydrogenase 1

Ensembl ID : ENSELUG00000005135
Gene Symbol: NQO1
1 Cross references
157 Possible Orthologues:

Nad(P)h Quinone Dehydrogenase 1

Ensembl ID : ENSELUG00000005112
Gene Symbol: NQO1
1 Cross references
157 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSELUG00000003914
Gene Symbol: NPC1L1
4 Cross references
190 Possible Orthologues:

P2x Purinoceptor 3

Ensembl ID : ENSELUG00000024531
Gene Symbol: LOC105028897
3 Cross references
194 Possible Orthologues:

P2x Purinoceptor 4-Like

Ensembl ID : ENSELUG00000001895
Gene Symbol: LOC109614602
3 Cross references
195 Possible Orthologues:

P2y Purinoceptor 12

Ensembl ID : ENSELUG00000009842
Gene Symbol: LOC105006525
3 Cross references
182 Possible Orthologues:

Pax-Interacting Protein 1

Ensembl ID : ENSELUG00000021419
Gene Symbol: LOC105012081
2 Cross references
193 Possible Orthologues:

Pim-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSELUG00000011885
Gene Symbol: PIM1
3 Cross references
250 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSELUG00000008794
Gene Symbol: PIM3
4 Cross references
174 Possible Orthologues:

Rac-Beta Serine/threonine-Protein Kinase

Ensembl ID : ENSELUG00000024251
Gene Symbol: LOC105024916
4 Cross references
185 Possible Orthologues:

Raf Proto-Oncogene Serine/threonine-Protein Kinase-Like

Ensembl ID : ENSELUG00000017588
Gene Symbol: LOC105029139
3 Cross references
207 Possible Orthologues:

Ring Finger Protein 151

Ensembl ID : ENSELUG00000007417
Gene Symbol: LOC105013116
3 Cross references
510 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).